Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Eiichi Sato(Shinmatsudo Central General Hospital), Kunle Odunsi(University of Chicago), Yao‐Tseng Chen(Memorial Sloan Kettering Cancer Center), James L. Kepner(Memorial Sloan Kettering Cancer Center), Christine B. Ambrosone(Unknown), Denise Frosina(Memorial Sloan Kettering Cancer Center), Gerd Ritter(Memorial Sloan Kettering Cancer Center), Sara H. Olson(Memorial Sloan Kettering Cancer Center), Achim A. Jungbluth(Gynecologic Oncology Group), Brian N. Bundy(Memorial Sloan Kettering Cancer Center), Haruo Ohtani(Memorial Sloan Kettering Cancer Center), Jiyoung Ahn(New York University), Sacha Gnjatic(Tisch Hospital), Tosin Odunsi(Memorial Sloan Kettering Cancer Center), Lloyd J. Old(Gynecologic Oncology Group), Feng Qian(Shanghai Public Health Clinical Center), Shashikant Lele(Memorial Sloan Kettering Cancer Center), Hiroyoshi Nishikawa(Immunité et Cancer)
Cited by 2,388
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma
|New England Journal of Medicine|2012|2.1k
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k